脑梗死急性期使用中医临床路径进行治疗的效果观察

目的:探讨分析脑梗死急性期使用中医临床路径进行治疗的效果。方法:以2015年5月至2016年5月间我院收治的70例脑梗死急性期患者为研究对象,随机分为临床路径组与常规治疗组(各35例),常规治疗组患者给予常规对症与支持治疗,临床路径组采用中医临床路径模式进行治疗,随访观察3个月。结果:临床路径组临床治疗总有效率(91.43%)远高于常规治疗组(71.43%),NHSS评分、住院时间与治疗费用皆远低于常规治疗组,3个月内再住院率(11.43%)明显低于常规治疗组(31.43%),差异有统计学意义(P0.05)。结论:实施中医临床路径治疗脑梗死急性期患者,提高临床治疗疗效、改善神经功能、缩短住院时间、减少治疗费用、降低再住院率,具有更高的临床应用价值。

Chinese Medicine Treatment Pathway in Acute Cerebral Infarction

To investigate the effect of acute cerebral infarction by TCM clinical treatment pathway.Methods:Total 70 cases of acute cerebral infarction between May 2015 to May 2016 in our hospital were randomly divided into clinical pathway group and conventional therapy group with 35 cases in each group.The conventional therapy group adopted the general symptomatic and supportive treatment,and the clinical pathway group adopted the TCM clinical path mode treatment,and followed-up lasted for 3 months.Results:Total effective rate of the clinical pathway group (91.43%)was much higher than conventional clinical therapy group (71.43%),NHSS score,duration of hospital stay and treatment costs of the clinical pathway group were much lower than the conventional treatment group,the readmission rate within 3 months of the clinical pathway group (11.43%) was significantly lower than the conventional treatment group (31.43%) (P<0.05).Conclusion:Clinical medicine pathway treatment is effective in acute cerebral infarction patients in improving clinical efficacy and nerve function,shortening time of hospitalization,reducing treatment costs and readmission rates,which is worthy of clinical application.